# Evernow

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/evernow

- Industry: Healthcare
- Headquarters: San Francisco, US
- Website: www.evernow.com
- Total disclosed funding: $29M
- Latest round: Series B (Sep 30, 2022)
- Investors on record: 5

## About

Based in California, US, and founded in 2019 by its CEO Alicia Jackson, Evernow, Inc. operates as a telehealth company. In April 2022, Evernow, Inc. raised USD 28.5 million in a series A funding led by new investor New Enterprise Associates, with participation from other new investors, including 8VC, Coelius Capital, and Refactor Capital.

Evernow offers menopausal hormone therapy (MHT) treatments such as estradiol patches, estradiol pills, and paroxetine, an SSRI (selective serotonin reuptake inhibitor), which can be used to treat hot flashes and night sweats. The company also offers an online platform for women to contact doctors and obtain prescription medications. It provides 24/7 telephone support to its customers.

The company generates its revenue by charging a subscription of USD 129 per month.

The company plans to use the April 2022 funding to expand its team, build a member community, and leverage the company's extensive data and research that will focus on product development.

## Funding rounds

- Series B, Sep 30, 2022, $0.1M — New Enterprise Associates, Alumni Ventures Group
- Series A, Apr 6, 2022, $29M — New Enterprise Associates, 8VC, Refactor Capital, Coelius Capital

## Investors

- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series A, Series B
- 8VC (https://capitalatlas.ai/funds/8vc) — Series A
- Refactor Capital (https://capitalatlas.ai/funds/refactor-capital) — Series A
- Coelius Capital (https://capitalatlas.ai/funds/coelius-capital) — Series A
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series B